Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison

INTRODUCTION: This study aims to make an indirect comparison between enzalutamide and abiraterone acetate for mCRPC post-docetaxel. METHODS: A search for published phase 3 trials was performed with PubMed. Indirect comparisons of enzalutamide (AFFIRM) to abiraterone acetate (COU-AA-301) on outcomes...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tan, Pui S, Haaland, Benjamin, Montero, Alberto J, Kyriakopoulos, Christos E, Lopes, Gilberto
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Libertas Academica 2014
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3964205/
https://ncbi.nlm.nih.gov/pubmed/24678245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S13671
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak